[1] Global Initiative for Asthma. Global strategy for asthma management and prevention, 2024. Updated May 2024.
[2] IHME. Global burden of disease study 2021 (GBD2021) data resources. https://vizhub.healthdata.org/gbd-results/.
[3] Tang KL, Huang JF, Xie SJ, et al. Temporal trend in burden of asthma in China, South Korea, and Japan, 1990-2019: results from the global burden of disease study 2019. J Thorac Dis, 2023; 15, 2559−70. doi:  10.21037/jtd-23-22
[4] Cao Y, Chen SQ, Chen XY, et al. Global trends in the incidence and mortality of asthma from 1990 to 2019: an age-period-cohort analysis using the global burden of disease study 2019. Front Public Health, 2022; 10, 1036674. doi:  10.3389/fpubh.2022.1036674
[5] GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the global burden of disease study 2021. Lancet, 2024; 403, 1989−2056. doi:  10.1016/S0140-6736(24)00476-8
[6] GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021. Lancet, 2024; 403, 2133−61. doi:  10.1016/S0140-6736(24)00757-8
[7] GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the global burden of disease study 2021. Lancet, 2024; 403, 2204−56. doi:  10.1016/S0140-6736(24)00685-8
[8] Wang ZF, Li Y, Gao Y, et al. Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the global burden of disease study 2019. Respir Res, 2023; 24, 169. doi:  10.1186/s12931-023-02475-6
[9] Luo Y, Wang M, Tian YM. Trends and age-period-cohort effects on incidence and mortality of asthma in Sichuan Province, China, 1990-2019. BMC Pulm Med, 2022; 22, 298. doi:  10.1186/s12890-022-02059-y
[10] Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr, 2019; 7, 246. doi:  10.3389/fped.2019.00246
[11] Sterling YM. Impact of the environment on asthma control. J Community Health Nurs, 2012; 29, 143−53. doi:  10.1080/07370016.2012.697844
[12] Murrison LB, Brandt EB, Myers JB, et al. Environmental exposures and mechanisms in allergy and asthma development. J Clin Invest, 2019; 129, 1504−15. doi:  10.1172/JCI124612
[13] Tong XL, Yin P, Liu W, et al. Spatial, temporal and demographic patterns in asthma mortality in China: a systematic analysis from 2014 to 2020. World Allergy Organ J, 2023; 16, 100735. doi:  10.1016/j.waojou.2022.100735
[14] Li XC, Guo MZ, Niu Y, et al. Secular trends of asthma mortality in China and the United States from 1990 to 2019. Chin Med J (Engl), 2024; 137, 273−82. doi:  10.1097/CM9.0000000000002855
[15] World Economic Forum. Global gender gap report 2024. https://www.weforum.org/publications/gender-gap-report-2024/.
[16] Gonzalez-Garcia M, Caballero A, Jaramillo C, et al. Prevalence, risk factors and underdiagnosis of asthma and wheezing in adults 40 years and older: a population-based study. J Asthma, 2015; 52, 823−30. doi:  10.3109/02770903.2015.1010733
[17] Baptist AP, Busse PJ. Asthma over the age of 65: all's well that ends well. J Allergy Clin Immunol Pract, 2018; 6, 764−73. doi:  10.1016/j.jaip.2018.02.007
[18] Skaaby T, Taylor AE, Thuesen BH, et al. Estimating the causal effect of body mass index on hay fever, asthma and lung function using Mendelian randomization. Allergy, 2018; 73, 153−64. doi:  10.1111/all.13242
[19] Lin P, Zhao YA, Shi YJ, et al. Associations of asthma control with hypertension, cardiovascular disease, and mortality in obese individuals. Intern Emerg Med, 2024; 19, 951−7. doi:  10.1007/s11739-024-03554-2
[20] Norbäck D, Lu C, Wang J, et al. Asthma and rhinitis among Chinese children - Indoor and outdoor air pollution and indicators of socioeconomic status (SES). Environ Int, 2018; 115, 1−8. doi:  10.1016/j.envint.2018.02.023
[21] Boulet LP, Boulay MÈ. Asthma-related comorbidities. Expert Rev Respir Med, 2011; 5, 377−93. doi:  10.1586/ers.11.34
[22] Kosmalski M, Różycka-Kosmalska M, Witusik A, et al. The coincidence of diabetes mellitus and asthma, their probable causal relationships and therapeutic opportunities. Adv Respir Med, 2020; 88, 590−8. doi:  10.5603/ARM.a2020.0168
[23] Wu TD. Diabetes, insulin resistance, and asthma: a review of potential links. Curr Opin Pulm Med, 2021; 27, 29−36. doi:  10.1097/MCP.0000000000000738
[24] Mitchell EA, Beasley R, Keil U, et al. The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from phase three of the ISAAC programme. Thorax, 2012; 67, 941−9. doi:  10.1136/thoraxjnl-2011-200901
[25] Rhedin S, Lundholm C, Osvald EC, et al. Pneumonia in infancy and risk for asthma: the role of familial confounding and pneumococcal vaccination. Chest, 2021; 160, 422−31. doi:  10.1016/j.chest.2021.03.006